title: Human antiglioma monoclonal antibodies from patients with astrocytic tumors.
abstract: The current management of malignant gliomas is unsatisfactory compared to that of other solid tumors; the expected median survival period is less than 1 year with the patient undergoing conventional surgery, radiotherapy, and chemotherapy treatment. Immunological reagents could be a useful adjunct. Human monoclonal antibodies derived from patients with astrocytic tumors might recognize subtle antigenic specificities that would differ from those recognized by xenogeneic (murine) systems. Five hybridomas, designated as BT27/1A2, BT27/2A3, BT32/A6, BT34/A5, and BT54/B8, were produced from the fusion of peripheral blood lymphocytes of four patients with astrocytic tumors to the human myeloma-like cell line TM-H2-SP2. This cell line has a 46, XX karyotype and is negative for hypoxanthine guanine phosphoribosyltransferase. All five human monoclonal antibodies produced 2.4 to 44 micrograms/ml of immunoglobulin M, had a similar but not identical pattern of reactivity against a panel of human tumor cell lines, and failed to react with normal human astrocytes. Labeling of four neuroectodermal tumor explant cultures by BT27/2A3 was demonstrated by flow cytometry. Karyotyping of three of the five hybridomas demonstrated that two were pseudodiploid (2-3n) and one hypodiploid (less than 2n). The monoclonality of the hybridomas was evaluated by Southern blot analysis of JH gene rearrangements, revealing two types of rearrangements for each hybridoma, both consistent with monoclonality. Preliminary antigen characterization indicated that at least four of the five human monoclonal antibodies were directed to cell-surface glycolipids.
authors.affiliation: Department of Neurology and Neurosurgery, McGill Cancer Centre, McGill University, Montreal, Quebec, Canada.
authors.forename: M D
authors.initials: MD
authors.lastname: Dan
authors.forename: C M
authors.initials: CM
authors.lastname: Schlachta
authors.forename: J
authors.initials: J
authors.lastname: Guy
authors.forename: R G
authors.initials: RG
authors.lastname: McKenzie
authors.forename: D R
authors.initials: DR
authors.lastname: Dorscheid
authors.forename: V A
authors.initials: VA
authors.lastname: Sandor
authors.forename: J G
authors.initials: JG
authors.lastname: Villemure
authors.forename: G B
authors.initials: GB
authors.lastname: Price
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D015139:Blotting, Southern; D001932:Brain Neoplasms / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005434:Flow Cytometry; D015321:Gene Rearrangement; D005803:Genes, Immunoglobulin; D005910:Glioma / Q000235:genetics / Q000276:immunology*; D006801:Humans; D006825:Hybridomas / Q000276:immunology*; D007075:Immunoglobulin M / Q000096:biosynthesis*; D007621:Karyotyping; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D007075:Immunoglobulin M